These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15722239)
41. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Blonski W; Vela M; Safder A; Hila A; Castell DO Am J Gastroenterol; 2008 Mar; 103(3):699-704. PubMed ID: 18341490 [TBL] [Abstract][Full Text] [Related]
42. Manometry and impedance characteristics of achalasia. Facts and myths. Agrawal A; Hila A; Tutuian R; Castell DO J Clin Gastroenterol; 2008 Mar; 42(3):266-70. PubMed ID: 18223498 [TBL] [Abstract][Full Text] [Related]
43. Regional esophageal dysfunction in scleroderma and achalasia using multichannel intraluminal impedance and manometry. Mainie I; Tutuian R; Patel A; Castell DO Dig Dis Sci; 2008 Jan; 53(1):210-6. PubMed ID: 17549634 [TBL] [Abstract][Full Text] [Related]
44. Detection of gastrointestinal tract events from multichannel intraluminal impedance measurements. al-Zaben A; Chandra V; Stuebe T Biomed Sci Instrum; 2001; 37():55-61. PubMed ID: 11347445 [TBL] [Abstract][Full Text] [Related]
45. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614 [TBL] [Abstract][Full Text] [Related]
53. New technologies to evaluate esophageal function. Ravi K; Francis DL Expert Rev Med Devices; 2007 Nov; 4(6):829-37. PubMed ID: 18035949 [TBL] [Abstract][Full Text] [Related]
54. Impedance detected abnormal bolus transit in patients with normal esophageal manometry. Sensitive indicator of esophageal functional abnormality? Koya DL; Agrawal A; Freeman JE; Castell DO Dis Esophagus; 2008; 21(6):563-9. PubMed ID: 18564161 [TBL] [Abstract][Full Text] [Related]
55. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing. Kline MM; Ewing M; Simpson N; Laine L Clin Gastroenterol Hepatol; 2008 Aug; 6(8):880-5; quiz 836. PubMed ID: 18424190 [TBL] [Abstract][Full Text] [Related]
56. Clinical Applications of Esophageal Multichannel Intraluminal Impedance Testing. Tutuian R; Castell DO Gastroenterol Hepatol (N Y); 2006 Apr; 2(4):250-258. PubMed ID: 28286455 [TBL] [Abstract][Full Text] [Related]
57. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. Blonski W; Vela MF; Freeman J; Sharma N; Castell DO J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553 [TBL] [Abstract][Full Text] [Related]
58. How to Optimally Apply Impedance in the Evaluation of Esophageal Dysmotility. Patel A; Gyawali CP Curr Gastroenterol Rep; 2016 Nov; 18(11):60. PubMed ID: 27738965 [TBL] [Abstract][Full Text] [Related]
59. Characterization of intraluminal impedance patterns associated with gas reflux in healthy volunteers. van Wijk MP; Sifrim D; Rommel N; Benninga MA; Davidson GP; Omari TI Neurogastroenterol Motil; 2009 Aug; 21(8):825-e55. PubMed ID: 19368658 [TBL] [Abstract][Full Text] [Related]